ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc (ENTA)

6,83
-0,44
(-6,05%)
Beim Schlusskurs: 13 März 9:00PM
6,83
0,00
( 0,00% )
Nach Börsenschluss: 11:16PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
6,83
Gebot
6,10
Fragen
7,36
Volumen
246.812
6,81 Tagesbereich 7,295
4,71 52-Wochen-Bereich 17,80
Marktkapitalisierung
Handelsende
7,27
Handelsbeginn
7,26
Letzte Trade
1
@
6.5
Letzter Handelszeitpunkt
21:06:21
Finanzvolumen
US$ 1.720.292
VWAP
6,9701
Durchschnittliches Volumen (3 Mio.)
557.148
Ausgegebene Aktien
21.332.544
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,26
Gewinn pro Aktie (EPS)
-5,44
Erlöse
67,64M
Nettogewinn
-116,05M

Über Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of... Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Enanta Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENTA. The last closing price for Enanta Pharmaceuticals was US$7,27. Over the last year, Enanta Pharmaceuticals shares have traded in a share price range of US$ 4,71 to US$ 17,80.

Enanta Pharmaceuticals currently has 21.332.544 shares in issue. The market capitalisation of Enanta Pharmaceuticals is US$155,09 million. Enanta Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.26.

ENTA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.15-2.148997134676.987.4256.42589597.11947238CS
40.6710.87662337666.168.766.164863397.73589262CS
120.9415.95925297115.898.764.715571486.14208001CS
26-5.52-44.696356275312.3513.36994.713960207.32956522CS
52-7.67-52.896551724114.517.84.712848169.38812041CS
156-58.27-89.508448540765.179.4954.7126205923.55837867CS
260-45.17-86.8653846154521024.7122431733.15447802CS

ENTA - Frequently Asked Questions (FAQ)

What is the current Enanta Pharmaceuticals share price?
The current share price of Enanta Pharmaceuticals is US$ 6,83
How many Enanta Pharmaceuticals shares are in issue?
Enanta Pharmaceuticals has 21.332.544 shares in issue
What is the market cap of Enanta Pharmaceuticals?
The market capitalisation of Enanta Pharmaceuticals is USD 155,09M
What is the 1 year trading range for Enanta Pharmaceuticals share price?
Enanta Pharmaceuticals has traded in the range of US$ 4,71 to US$ 17,80 during the past year
What is the PE ratio of Enanta Pharmaceuticals?
The price to earnings ratio of Enanta Pharmaceuticals is -1,26
What is the cash to sales ratio of Enanta Pharmaceuticals?
The cash to sales ratio of Enanta Pharmaceuticals is 2,15
What is the reporting currency for Enanta Pharmaceuticals?
Enanta Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Enanta Pharmaceuticals?
The latest annual turnover of Enanta Pharmaceuticals is USD 67,64M
What is the latest annual profit for Enanta Pharmaceuticals?
The latest annual profit of Enanta Pharmaceuticals is USD -116,05M
What is the registered address of Enanta Pharmaceuticals?
The registered address for Enanta Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Enanta Pharmaceuticals website address?
The website address for Enanta Pharmaceuticals is www.enanta.com
Which industry sector does Enanta Pharmaceuticals operate in?
Enanta Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 28,75
(110,47%)
31,16k
MRMMEDIROM Healthcare Technologies Inc
US$ 1,10
(77,42%)
3,76M
AAOIApplied Optoelectronics Inc
US$ 26,30
(65,72%)
2,21M
BTOGBit Origin Ltd
US$ 0,3714
(36,09%)
2,7M
PRPLPurple Innovation Inc
US$ 0,83
(25,09%)
3,47M
MKDWMKDWELL Tech Inc
US$ 0,3214
(-21,15%)
4,13k
NAYANAYA Biosciences Inc
US$ 0,255
(-20,59%)
102,29k
LGCBLinkage Global Inc
US$ 0,1831
(-19,83%)
5,8M
RGCRegencell Bioscience Holdings Ltd
US$ 11,30
(-19,80%)
1,81M
HMRHeidmar Maritime Holdings Corporation
US$ 3,46
(-15,20%)
1,54M
ICONIcon Energy Corporation
US$ 0,126
(-7,35%)
9,7M
LGCBLinkage Global Inc
US$ 0,1831
(-19,83%)
5,8M
ADTXAditxt Inc
US$ 0,0329
(-1,50%)
5,01M
DGLYDigital Ally Inc
US$ 0,083
(4,53%)
4,26M
HEPAHepion Pharmaceuticals Inc
US$ 0,0368
(-2,65%)
3,89M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen